In this regard, the hyperactivation of mTOR-downstream S6K that we found in this SCCOPT case indicates the similarity of this tumor to SCLC, suggesting that it was potentially targetable with mTOR inhibitors. Here, RPS6KB1 is linked to neoplasm.